ARCHIVES

Cancer Programs Close Amid Gridlock

This article is from The Cancer Letter archive.

Vol. 39 No. 37 | October 4, 2013

Download PDF Visit The Full Archive

Related Articles

Harkin to Ask NCI For Accounting Of Antineoplaston Trials

July 2, 1993

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

Hopkins, Pennsylvania Ok’d As Comprehensive; No. Remains At 24

May 24, 1991

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

August 8, 1980

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004